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Mode of action of drugs:
It is usually supposed that drugs produce their
biological effects as a result of physical or chemical
interactions with cells. In many instances these
interactions are limited to particular types of cell,
e.g. muscle cells or nerve cells, and are a consequence
of the combination of the drug with these cells. This
combination may produce an effect comparable with normal
physiological or biochemical processes, in which case
the compound is referred to as an agonist. More often,
the combination produces an effect by blocking normal
processes and the compound is referred to as an
antagonist.
Some substances, such as caffeine and normal ali¬
phatic alcohols only produce their effects when given in
amounts sufficient to form a monomolecular layer over
the whole area of the cell (Clark, 1937a). This suggests
that these drugs probably act by some physical or
physicochemical process. Such a mechanism has been
suggested, for instance, for the actions of anaesthetics
(Meyer, 1901; Overton, 1901).
In contrast, Clark (1933) calculated that potent
drugs such as acetylcholine, adrenaline, histamine and
atropine could produce appreciable effects when given in
amounts which could only cover a small fraction of the
cell surface. These observations favour the idea,
originally put forward by langley in 1878, that many
drugs act by combining with a small area on the cell
3.
referred to as the "receptive substance" (langley, 1905).
This idea of "receptive substance" or "receptors" was
used extensively by Ehrlich (1913) in his work in chemo¬
therapy.
Similar ideas have been developed for the inter¬
actions of a substrate and the "active spots" on an
enzyme (Michaelis and Menten, 1913) and for the
adsorption of gas molecules on metal surfaces (Langmuir,
1916, 1918).
Clark (1937a) applied Langmuir's adsorption iso¬
therm to the combination of drug with the receptor. If
the drug, A, is combining reversibly with the receptors,
R, giving a complex which somehow leads to a response,
A + R=s=^A R response,
and if a proportion, y, of receptors is occupied by drug
and the concentration of drug is A,
the rate of formation of the complex = k^ A(l-y)
and the rate of break down of the complex = kgy.
At equilibrium, k^A (l-y) = k£y and hence
KA = (I)
or y = T~+TA
kl
where K = r— , the affinity constant.
2
If Ag" is the concentration which occupies half the
receptors, A-g- =
If the response is directly proportional to y then
4.
when half the receptors are occupied the response will
be half the maximum and by measuring the concentration
of A which produces half the maximum response, we can
obtain K. Although Clark suggested that affinity
constants might be obtained in this way he himself said
that the underlying assumptions were unlikely and these
have subsequently been strongly criticised by Stephenson
(1956).
If the ability of a drug to produce an effect
depends upon the amount of complex formed, the affinity
constant for the receptors will definitely be important
because it determines the amount of the complex formed.
This cannot be the only property involved, however,
because some compounds, when adsorbed, do not produce an
effect and act as antagonists, because they lack the
ability to activate the receptors. In addition to
antagonists there are compounds which have some ability
to activate the receptors but which may not produce a
maximum response from the tissue, however much is given.
These have been called partial agonists (Stephenson,
1956) or competitive dualists (Ariens, 1954) and it is
assumed that these have an efficacy (Stephenson) or
intrinsic activity (Ariens) intermediate between potent
agonists and antagonists. Paton (1961) has postulated
that the ability of a drug to activate a receptor
of
depends upon the rate/dissociation of the drug receptor
complex, consequently partial agonists are compounds
5.
with values of kg intermediate between those of agonists
and antagonists.
Ariens (1954) assumed that the response is directly
proportional to the number of receptors occupied and to






ay a 1 + AK,
50
, where A^q is the concentration
producing a response which is 50 per cent, of the
maximum of which the tissue is capable. Ariens uses
X
values of log — which he calls pD0, as if it were a
50 2
measure of the affinity and calculates a from the size
of the maximum contractions which can be produced by the
tissue.
Stephenson (1956), on the other hand, avoids this
assumption by introducing another quantity, S, the bio¬
logical stimulus, which is some function of R, the
response, R = f (S). He defines the stimulus, S, as
the product of efficacy (e^)of the drug and the propor¬
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Many compounds which act like acetylcholine appear
to have the same intrinsic activity ( a= 1). This is
very different from what is observed with the substrates
of an enzyme where it is most unusual to find the sub¬
strates with the same value of k^, the rate constant for
the break down of enzyme-substrate complex into products.
It raises the question whether the size of the maximum
response is a function of the tissue rather than, or as
well as, of the drug, i.e. whether some compounds do not
stimulate the tissue so that it contracts as much as it
is able, when y is only small (as suggested by Stephen¬
son, 1956). Evidence for this has been produced by
Eickerson (1956), who suggests that a maximum response
of the tissue can be obtained by the combination of
drugs such as histamine with only as little as 1 per
cent, of the histamine receptors. Similar results have
been reported by Purchgott (1955) with adrenaline and
adrenergic receptors.
In these circumstances, when y is small,
AK1 - T"-"~y —» y
i.e. response = f(e^y) = f(©A
so, according to Paton's theory, k2y = k^^A = ^"1A
Even with this approximation, it is still impossible
to obtain e^ or K^. If two compounds, and A2,
produce identical responses, the biologioal stimulus
produced will be the same for both, i.-ev eo A| K-^ 'h,
7.
Kg, where the compound Ap present in concentration
Ap has an efficacy e^ and an affinity K-^ and the
compound Ag, present in concentration Ag, has an
efficacy e2 and an affinity Kg. Although A-^/Ag is
known from the experiments there is still no means of
obtaining separately e^, e2, k-^ and kg.
The effects produced by an agonist, therefore,
depend upon two parameters, its affinity (K) and its
efficacy (e) or the dissociation-rate constant (kg) and
there is no simple means of estimating these separately.
As already mentioned, some drugs combine with
receptors but do not activate them and block the actions
of agonists. If A is the agonist and B the antagonist
and both are present together,
A + R AR ?> Response
i.e. Agonist + Receptor ;==^ complex >> Response
B + R ^ " BR
i.e. Antagonist + Receptor ^complex
If the agonist molecule in concentration (A)
occupies a proportion, y, of the receptors and if the
antagonist in concentration (B) occupies a proportion,
z, we can write,
KA = (A) (1 - y - z)
or y = ka(a) (1 - y - z) (YI)
where K^ is the affinity constant for agonist and the
receptor.
8.
KtLB ~ (B) (1 - y - z)
or z = Kb(B) (1 - y - z) (VII)
where is the affinity constant for the antagonist and
the receptor.
From VI and VII we can derive,
'
(A) Ka = (1 I y) (1 + (B) Kb) (VIII)
When no antagonist is present this becomes ^ ^ ^ as
equation (I).
Now, if the biological response to a concentration
of (A) of agonist in the presence of a concentration (B)
of antagonist is the same as that 't0 a concentration (a)
of agonist alone, it follows from equation (VIII),
A
~ 1 + (B) Kb (Gaddum, 1937)a
or Kb = A^b) 1 (IX)
A/a is called the dose-ratio; when A/a is 10,
the concentration of the antagonist necessitates a 10-
fold increase of agonist concentration in order to keep
the response constant.
This equation is not based on any assumption about
the relationship between biological stimulus and the
size of the response, because the size of the response
is kept constant. Moreover, the value of K-n will be
the same whatever may be the concentration of antagonist
used, so long as it acts competitively. This is an
9.
absolute measure of the activity of an antagonist. In
addition, it is independent of the affinity and efficacy
of the agonist, provided only that the agonist and
antagonist are competing for the same receptors.
Schild (1947) has applied this equation to devise a
method for measuring antagonist activity. Responses
are ohtained with the agonist alone and then in the
presence of a concentration, (B), of antagonist such
that twice the concentration of agonist must be given to
keep the response constant. The dose-ratio, therefore,
1
is 2 and log yjyy = log K.
Scott (Ph.D. thesis, 1962) has modified this
procedure by testing a number of concentrations of
antagonist and determined their dose-ratios. He used
the values of the dose-ratios to obtain a number of
estimates of the affinity constants and also plotted the
(dose-ratio - 1) against (B), the antagonist concentra¬
tion, to see whether the compound behaved competitively.
Whatever method is selected, the activity of a
competitive antagonist can be expressed in terms of its
affinity.
Scott's method for measuring affinity constants was
developed because he was interested in studying changes
in affinity in series of antagonists obtained by
replacing methyl substituents by ethyl in a trimethyl-











where the compounds in the first column were all
antagonists and R was PhgCHCOOCHgCHg-, Ph2C(0H)C00CH2CH2-,
Ph2CHCH20CH2CH2-, Ph2CH0CH2CH2CH2- and
Ph2CHCH2CH2CH2C0CH2- .
He measured the affinity constants of all these
compounds. The compounds in the second column were
similar hut lacked the two benzene rings, i.e. R' was
CH3C00CH2CH2-, CH3CH2OCH2CH2-, CH30CH2CH2CH2- and
CH,CHoCHoCHoC0CHo- and he measured their equipotent3 2 2 2 2 tQ
molar ratios relative/acetylcholine. Most of these
compounds are agonists. It was thought that if the
change in affinity, produced by replacing methyl by
ethyl, was the same in the agonists as it was in the
corresponding antagonists, it would be possible to
assess the effect of replacing methyl groups by ethyl on
the efficacy. When two agonists with affinity constants
and K^, and efficacies e^ and e^, respectively,
produce comparable responses in concentrations A and A',
the biological stimulus should be the same, i.e. if the












The suggestion that for example, for
A'
+ +
CH3COOCH2CH2NMe5 and CH^OOOCHgCHgNMe^t, is the same as
+
the ratio of the affinity constants of PhgOHCOOCHgCHgKMe^
+
and Ph'2CHC00CH2CH2Me2Et is based on the following argu¬
ment. The affinity constant, K, is related to the free
energy of adsorption (by the equation,
AY = -RT logeKA
or log10KA = 2.3 RT
The change of methyl for ethyl increases the binding by
an increment which could be due simply to the presence
of the extra methylene group, consequently for the com¬
pound with one ethyl group,
loe* K — + 8-)g10 A' " 2.3 RT
KA* - aand a _ a
Ka ~ 2.3 RT
This is independent of and should, therefore,
be the same for both agonists and antagonists, provided
always that the onium group is bound in the same way in
both the series of compounds, and that the replacement
12.
of methyl by ethyl does not interfere with the binding
of the rest of the molecule (i.e. alter in one
series but not in the other).
In the five series of antagonists studied by Scott
there was a fairly regular change in affinity with
increasing replacement of methyl groups, even though the
actual affinity constants differed by a factor of 200.
The affinity was invariably increased by replacement of
one or two methyl groups by ethyl but declined towards
its original value when the third methyl group was
replaced. The activity of those of the compounds which
were agonists declined markedly with the replacement of
methyl by ethyl and from this it was concluded that the
change in structure was producing a marked change in
efficacy.
The assumption that the effects of replacing methyl
by ethyl are the same in the agonists as they are in
antagonists has been criticised by Burgen (1965) who has
obtained results which suggest that the onium group in
the antagonists may be held further away from the
negatively charged group on the receptors with which it
.
interacts, than is the onium group in agonists. He
suggested that the ability of the onium group to come
close to the receptor may determine its ability to act
'
as an agonist.
These ideas, however, are based only on observations
with the two pairs of compounds, acetylcholine and
13.
3-3-dimethylbutylacetate and benziloylcholine and (3-3-
dimethylbutyl)benziloate and clearly much more informa¬
tion is needed. Results obtained by Abramson (1964)
suggested that there were differences in the effects of
chemical changes on the affinity of the series of
antagonists when a bigger variety of groups was studied.
The aim of the present work was therefore:
I. To extend the work of Scott and Abramson to see
whether the effects of changes in chemical structure on
affinity are similar in various series of antagonists
and, if they are not, to try to discern what similarity
there is between the various series. Although Scott
had found that the effects of replacing methyl by ethyl
in the onium group were similar in five series of
antagonists, Abramson found that replacement of methyl
groups by pyrrolidino and piperidino groups had
different effects in the diphenylacetyl and benziloyl
derivatives, even though effects of replacing methyl by
ethyl in these series were exactly the same.
II. To study the effect of temperature on the affinity
of the compounds, and also to see if the affinity con¬
stants were the same when different agonists were used
and also other tissues containing muscarine-sensitive
acetylcholine receptors.
The componnds studied were:
+ + +




2. Ph2CH(CH2)4KR3, Ph2CHCH2OCH2CH2NR3 and
+
OycloHex(Ph)CHC OOCH2GH2NR5.
3. Tropine and pseudo'tropins •, meth- and eth-iodides and
their benziloyl and diphenylacetyl esters.
4* + + + +




For convenience the compounds of group 1 are termed
"lower analogues" of acetylcholine and those of group 2
"higher analogues" and those of group 3 "atropine
analogues". The term"body"is used to describe the main
bulk of the molecule apart from the onium group. In
the series, in groups 1 and 2 the body is therefore the
group Ph(CH2)ej- or Ph2CH(CH2)4-, etc., and in the com¬
pounds in group 3 it is the benziloyl or diphenylacetyl
tropyl residue.
Antagonists and competition
The methods used for measuring affinity constants
all assume that the antagonism is competitive. If it
is not, the antagonism cannot be expressed in terms of
an equilibrium constant. Although experiments may give
what should be an affinity constant, this will not, in




thesis it is most important to establish that the com¬
pounds are all competitive antagonists, acting in the
same way as each other.
Schild (1947, 1957) and Marshall (1955) have used
the difference between pA2 and pA1Q as a test for com¬
petition: pA2 is the log of the reciprocal of the con¬
centration of antagonist giving a dose-ratio of 2, and
pA-^Q the corresponding value for the concentration
giving a dose-ratio of 10. Consequently pA2 - PA-j_q
should be equal to log 9, if the antagonism is
c^iaA. iK t jUf/HsiCU-Yi'i*#*-is ri-ccAitxexL-
competitive/^ . This is not a particularly satisfactory
test because of the size of the errors in the estimation
of pA2 and pA-^q. Scott (1962) tested a number of con¬
centrations of antagonist and plotted (dose-ratio - 1)
against the concentration of antagonist. This should
give a straight line passing through the origin and
Scott found this to be so. In these experiments Scott
obtained a log-dose-response curve and then exposed the
preparation to the antagonist and increased the concen¬
tration of the agonist. Prom the responses to this
concentration of agonist he calculated the dose-ratio
and he then repeated the procedure with a higher concen¬
tration of antagonist. The disadvantage of this method
is that, because responses are only obtained with one
concentration of the agonist in the presence of a parti¬
cular concentration of antagonist, there is no indication
whether the antagonist has altered the slope of the log-
16 •
■
dose-response curve. An alternative procedure is to
test many concentrations of agonist and observe whether
the log-dose-response curve is parallel with original,
obtained in the absence of antagonist (Gaddum, 1957;
Schild, 1957). The disadvantage with this procedure,
however, is that for a limited number of only a
limited range of concentrations of antagonist can be
tested. Unless a wide range is tested, results may be
obtained similar to those of Nickerson (1956) and Furch-
; !
gott (1955) who found that some antagonists appeared
initially to be competitive but were clearly non¬
competitive in higher concentrations. The apparently
competitive phase could be explained by supposing that
the action of the antagonist is really non-competitive,
but that the agonist is occupying only a small propor-
i
ition of the receptors. With the wide range of concen-
:trations used by Scott it would seem most unlikely that
a non-competitive antagonist could be mistaken for a
competitive one, but in the course of testing the com¬
pounds listed above it has been necessary to develop







1. The isolated guinea-pig ileum:
This preparation was set up as described by
Stephenson (1956).
A guinea-pig, which had been starved for 24 hours
and which weighed about 200-300 g., was killed by a blow
on the head and bled out. The abdomen was opened and
about 15 cm. of the terminal ileum was carefully
dissected out and placed in a dish containing Tyrode's
solution at about 30°C. The lumen of the gut was
washed through with warm Tyrode from a pipette, with
not more than 2-4 cm. of hydrostatic pressure to cause
peristaltic evacuation. The terminal 3-4 cm. containing
Peyer's patch was discarded and the adjacent 3 cm. of
the ileum was mounted in an organ bath containing
Tyrode's solution at 37°C., through which air was blown.
One end of the gut was attached by a thread to a frontal
writing lever writing on a smoked drum. The magnifica¬
tion of the lever was about five and the load was 0.5 g.
2. The isolated longitudinal muscle strip from guinea-
pig ileum (Rang, 1964; Paton and Rothschild, 1965):
A piece of guinea-pig ileum, 4-5 cm. long, was
freed from its mesenteric attachments and slipped, oral
end first, over a pipette having an external diameter of
0.5 cm., which was held at an angle of about 30° to the
19
horizontal by a clamp. A flap of the longitudinal
muscle coat was freed by gently rubbing the upper end of
the ileum with a wad of moist cotton wool, starting at
the mesenteric border. The process of peeling was con¬
tinued on either side of the mesenteric border till the
whole coat was freed at the upper end. A cotton liga¬
ture was tied to the free end of the flap. The muscle
strip was then gently pulled downwards while the
remainder of the gut was pulled upwards. The longitu¬
dinal coat was thus freed along its entire length without
being torn except at the mesenteric attachments. A
length of about 3 cm. of the muscle was then mounted in
.
an organ bath in a way similar to that described for the
whole ileum.
3. The isolated taenia coli of guinea-pig (Bulbring,
1954):
A guinea-pig was killed and the abdomen was opened.
The colon was exposed and the taenia muscle was identi¬
fied. A ligature was passed under it and tied and the
bundle of muscle was cut near this ligature; care was
taken not to penetrate the lumen of the gut. The cut
end was lifted up by the thread and the bundle was
separated from the underlying tissue by blunt dissection
i
jfor about 10 cm.; this was transferred to a dish con¬
taining Tyrode's solution. About 3 cm. of the taenia
coli was then cut off and a thread tied at each end; it
f
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was then mounted in the organ bath. The lever had a
magnification of about 7 and the load was 1 g. The
temperature of the bath was 37°C.
and
4. The rat colon preparation (Clark/Raventos, 1937;
1
Regoli and Vane, 1964)t
A rat, weighing about 300 g., was killed by a blow
on the head and bled out. The abdomen was opened and
the
the colon was identified by/transverse striations over
the ascending colon. The whole of the colon was
removed and the lumen was cleaned by flushing with warm
Tyrode's solution. A piece of colon about 2.5 cm. long
was then mounted in the organ bath as described for the
guinea-pig ileum.
The ascending colon and the transverse colon were
usually found to be loaded with hard faecal matter and
when tested were found to be less sensitive to carbachol
than the descending colon. Usually, therefore, a piece
of descending colon was used but even this took a longer
time to settle down than did a piece of guinea-pig ileum;
it was also slower in its response to drugs.
5. The isolated rabbit auricle preparation (Burn, 1952):
A young rabbit, weighing about 1000 g., was stunned
by a blow on the head and bled out. The chest was
:opened and the heart was dissected out and placed in a
dish containing oxygenated Locke's solution at about 30°C
All the tissues were quickly trimmed away until only the
21
auricles remained. A thread was attached to the tip of
each of the auricles; one of the threads was tied to a
fixed pin in the organ bath and the other was tied to a
strain gauge (force-displacement transducer, Model FT.03,
without spring - by Grass). The organ bath, which had
a capacity of about 45 ml., contained Locke's solution,
well aerated with a mixture of oxygen (95 per cent.) and
carbon dioxide (5 per cent.). The temperature was 37°C.
and contraction of the muscle was recorded with a
Devices Model M4-62 pen recorder.
Methods
1. The antagonist activity of the compounds was
estimated by determining their affinity constants for
the post-ganglionic acetylcholine receptors in the
guinea-pig ileum, at 37°C.
In a few experiments, the method of Barlow,Scott
and Stephenson (1963) was followed exactly, but in most
of them two concentrations of agonist were tested in the
presence of the antagonist, using a modification of the
j
procedure, instead of only one concentration. The
dose-ratio was measured by a 4-point assay. Responses
were obtained with two concentrations of carbachol
chloride (usually 6-8 x 10~^ M and 1.2-1.6 x 10 M);
when these were steady, the Tyrode's solution was re¬
placed by the Tyrode's solution containing the antagonist
and the responses were obtained with higher concentra-
—7
tions of carbachol (usually 6-8 x 10 M and 1.2-1.6 x
—610~ M, because the concentration of the antagonist was
deliberately chosen so as to produce a dose-ratio of
about 10). In some experiments, however, higher con-
centrations of antagonist were tested and the concentra-
tions of the agonist were increased as necessary.
The apparatus used was similar to that described by
Stephenson (1956). The drug solutions were made up to
the desired concentrations in Tyrode's solution and
placed in reservoirs above the bath. At the appropriate
time this was allowed to flow into the bath by the
25
machine and subsequently washed out by upward displace¬
ment with fresh solutions. The drugs were in contact
with the tissue for 30 sec. and the preparation was left
for 60 sec. to recover. The drugs were, therefore,
added once in every 90 sec. When steady responses were
obtained with the high and low concentrations of the
agonist (usually within an hour from the starting of the
experiment) a 6-way tap, connecting the bath with glass
coils, was turned and the tissue was exposed to the
Tyrode's solution containing antagonist, and the two
higher concentrations of the agonist also containing the
same concentration of antagonist. The cycle was then
continued until these responses were also steady and
roughly comparable with those obtained initially with
agonist alone (Figure I).
The procedure, therefore, resembled a 4-point assay
in that responses were obtained with high and low con¬
centrations of the standard and high and low of the
unknown (agonist and antagonist) but differed from it in
that it was not possible to arrange the order in which
these were given (in a random fashion or according to a
latin square).
The volume of the bath was 3 ml. and that of the
glass coils, connecting the bath with the reservoir, was
25 ml. and the volume of the fluid to wash the prepara-
tion was 12 ml. and in these conditions sufficient fluid
could run through the bath to effect complete exchange
FIGURE I. Typical assay used to determine the affinity
constant of an antagonist. Initial responses were due
to carhachol, 0.6 and 1.2 x 10 ?M. At the arrow the
Tyrode's solution was changed to Tyrode's solution
containing the antagonist, phenylpentylethylpyrrolodinium
—5
4.8 x 10 I, and the concentrations of carhachol were
increased to 12 and 24 x 10~7m.
24
without exposing the tissue to the air and without
cooling more than 0.1°C.
Hexamethonium "bromide, 2.75 x 10"^ M (100 mg./li'tre),
was added to the Tyrode's solution to ensure that drugs
were acting on post-ganglionic acetylcholine receptors.
All the experiments except those with rabbit
auricles were performed with this procedure.
2. Rabbit auricles:
A few of the compounds were tested on the rabbit
auricles in a similar way as on the guinea-pig ileum.
The usual rate of beating was recorded and then a dose
I
of carbachol was added to the bath from a blow-out
pipette and rate of beating was again recorded. After
45 sec. the preparation was washed twice with Locke's
solution and allowed to recover for 94 minutes (conse¬
quently a dose of carbachol was added once in every 10
minutes). The effect of the dose of carbachol was
measured by calculating the percentage reduction in the
rate of beating. When steady responses were obtained
with high and low doses of carbachol the preparation was
exposed to a concentration of the antagonist and
responses were then obtained with still higher doses of
an^
the agonist (the concentration of the agonist selected,
so as to produce a dose-ratio of 10). Prom the dose-
ratio, the affinity constant was calculated as described
oJqovz. ,
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3. The effect of temperature on the affinity constant:
To see how the affinity constants of the antagonists
vary with the temperature, a few of the compounds were
tested both at 37°C. and 27°C. In some experiments the
measurement was made first at 27°C. then at 37°C. and in
other experiments the order was reversed.
The method of working out the results is based on
the procedure described by Schild (1942) and by Gaddum
(1954) and is illustrated by the following example:
Test compound, phenylpentyl (ethyl pymolidinium),
4.8 x 10~5 M (G)
Heights of contractions in mm.
(i) Carbachol (ii) Garbachol + (C)
6 x 10"8 1.2 x 10~7 1.2 x 10~6 2.4 x 10 6
65 80 63 79
65 78 62 80
66 80 63 80
65 80 62 78
64 80 63 79
Total 325 399 313 396
Mean 65.0 79.8 62.6 79.2
26
From (i) and (ii),
The mean slope =
14.8 + 16.6 31.4
2d
d = log. ratio
2d between the




Hence, the log. dose-increment = 3.0 x 0.30131.4 0.0288
Hence taking antilog. and multiplying by 20, we get,
Each compound was tested on at least 5 different
pieces of tissue, usually 7 or 8, and the mean of the
logarithm of these individual values was calculated
together with their standard error and the fiducial
limits at a level of probability of 95 per cent.
4. A test for competitive antagonism:
In the present work the affinity constant of the
antagonist was measured by applying Gaddum's equation
(1937), i.e. assuming the compound to be a competitive
antagonist. It was, therefore, necessary to check this.
Barlow, Scott and Stephenson (1963) had tested several
concentrations of the antagonist and found that the
result fitted Gaddum's equation, i.e. the graph of dose-
ratio minus one against the antagonist concentration was
linear and passed through the origin/• With less active
A/a (dose-ratio) = 1.069 x 20 = 21.38
















FIG.II . Graph of dose-rat io($|j)-l, against antagonist
concentration. Linear relationship indicates
competitive antagonism.
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compounds it was not possible to test a wide range of
concentrations. When some of the compounds were tested
it seemed that they might not be acting competitively at
(Fig.IIA)
high concentrations/ so the following method was devised
to see whether they were acting competitively in the
lower concentrations .
Responses were obtained to the agonist and then to
the agonist in the presence of a concentration (B) of
atropine (a truly competitive antagonist) which produced
a dose-ratio of about 100; the agonist was then tested
in the presence of this concentration (B) of atropine
together with a concentration of the antagonist under
investigation (C) which by itself produced a dose-ratio
of about 10.
If both the antagonists are competitive,
(1 + bkb - 0Kc>
where y is the proportion of the receptors occupied by
the agonist (whose concentration is A and affinity
constant K^) in the presence of a concentration B of the
antagonist (atropine), affinity constant Kg) and a con¬
centration G of the antagonist under test (affinity
constant K^). If the same responses were produced by
a of the agonist alone, by Ag of the agonist in the
presence of B, by A of the agonist in the presence of C
and by Agc of the agonist in the presence of both B and C
together, it is reasonable to assume that y is the same
MOLAR CONCENTRATION
FIG.lift. Graph of dose-ratio (jjj)-l against antagonist
concentration. Linear relationship at lower
concentration indicates competitive antagonism.
Non-linear relationship at higher concentration
indicates non-competitive antagonism.
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in each situation and hence,
1 + BK-g (about 100 in this expt.)
1 + CKq (about 10 in this expt.)




1 + dose-ratio of C alone - 1
dose-ratio of B alone
If the antagonist c is truly competitive the dose-
Abc
ratio t— should be slightly greater than one (about
b
1.09). But if C is not competitive and is not displaced
from the receptors with increasing concentration of
Abc
agonist, the dose-ratio -?— will be exactly the same as
b
Ac
—, i.e. about 10.£1
Paton and Rang(1965- 66 ) reported a similar test-
With this method it was easy to check that C was
competitive at the lower concentration which was usually






FIGURE III. The atropine test for competition. Initial
responses were due to carbachol 0.6 and 1.2 x 10 M. At
the first arrow the Tyrode's solution was replaced "by
Tyrode's solution containing atropine 10 M. The
concentrations of carbachol were increased to 60 and
120 x 10 7M and the drum was stopped for l5 minutes
while preparation came into equilibrium with atropine
and then restarted. At the second arrow the Tyrode's
solution was again replaced by Tyrode's solution containing
the test compound, Phenylpentylethylpyrrolidinium,
~""5
U.8 x 10 M and atropine 10 7m and the drum was stopped
again for 10 minutes, after which it was restarted.




Test for competitive antagonism of carbachol with
— R
phenylpentyl (ethyl pyrrolidinium) 4.8 x 10 (0)
Example: Part 1 (Test compound (C) alone)
(1) Oarbachol Mean height (mm.)
6 x 10 8 M 75.4
1.2 x 10~7 M 85.8
(2) Carbachol with (C)
1.2 x 10"6 M 75.4
2.4 x 10~6 M 86.8
Erom (1) and (2),
10.4+11.4 21.8The mean slope = ^ = ga
,161.2 - 162.2 1.0
The preparation difference = g = ——
^ 1.0 x 0.301 0.0138
Hence the log. dose-increment = 01 = ■21,8 .9862
Taking the antilog. and multiplying by 20 we get the
dose-ratio 0.9687 x 20 = 19.34
30
Part 2 (Carbachol + atropine and
car"bachol + atropine + test compound (C))
(3) Carbachol Height ofcontractions (mm.)
6 x 10~8 1 25.90
1.2 x 10"7 M 34.30
(4) Carbachol + atropine
(10~7 I) (B)
6 x 10~6 I 24.63
1.2 x 10M 34.75
(5) Carbachol + atropine
(10~7 M) (B)
+ test compound (C)
6 x 10~6 M 23.00
1.2 x 10""5M 33.00
Prom (3) and (4),
8.40 + 10.12 18.52
The mean slope = ^—
,. 60.20 - 59.38 0.82
The preparation difference = p = —p—
it
j. 0.82 x 0.301 ^ m-z?
Hence the log.dose-increment = 18.52 = 0,0153
Taking the antilog. and multiplying by 100 we get,
1.031 x 100 = 103.10 (dose-ratio for atropine
10~7 M (B) alone)
31






The preparation difference 59-38 - 56.002
3.38
2
Hence the log. dose-increment = 3.38 x 0.30120.12
= 0.0506
Taking the antilog. and multiplying by 1 we get,
1.120 x 1 = 1.120 (observed dose-ration for (B)
and (0) together)
From Part 1 we had a dose-ratio for (C) alone of 19.34,
so, from the formula, the theoretical dose-ratio for (B)
and (C) together is,





The estimates of the affinity constants (Kg) "the
members of the 7 series of acetylcholine analogues are
shown in Tables I - VII and summarised in Table VILA.
The estimates of the atropine analogues are shown in
Tables VIII - XIII with a summary in Table XIV. The Table
XV summarises the results of the tests with atropine for
the competitive antagonism of some of the antagonists.
The effect of temperature on affinity is shown in Table
XVI. The effect on affinity for using different agonists
is shown in Tables XVII - XIX. The variation of affinity
constant with different tissues is shown in Tables XX -
XXIII.
These tables show the individual estimates of
affinity, the values of log Kg, the mean value of log Kg
with its upper and lower limits at a level of probability
of 0.05 shown in the parentheses.
The standard error of the mean, on the average,
for the acetylcholine analogues was 5.5 per cent. The
minimum percentage of error for these analogues was
I.8 per cent, and only in two compounds the percentages
of error were higher than 10, having values of 11.5 and
II.9 per cent. Similar errors have been observed in the
estimates of pA2 and pA10 values (Timms, 1956) and both
Scott (1962) and Abramson (196U) reported a standard




1• The phenylpentyl series (Table j)
The affinity constants for the members of the series
were calculated from experiments in which the dose-ratio
was mostly about 10. In some experiments with tri-
ethyl-ammonium compound it was higher and even as high
as about 300 but this did not appear to affect the
result. With the ethylpyrrolidinium compound, however,
there was an apparent increase in affinity constant with
higher concentrations. Only the results with lower
concentrations were included and at these concentrations
the compound appeared to be competitive when tested by
atropine method (page 26). The standard error of
estimates for each member lies within 2-6 per cent.
The mean value of log Kg for the series lies
between 5 and 6. The affinity increases by about two¬
fold for each successive replacement of methyl by ethyl
up to triethyl-ammoniumj this increase is statistically
highly significant. With the introduction of a
pyrrolidine ring the affinity fell sharply to a value
less than that of the methyldiethyl-ammonium compound.
The ethylpyrrolidinium and methylpiperidinium compounds
have much the same affinity but that of ethylpiperidinium
compound is again lower, comparable with that of the
ethyldimethyl ammonium compound.
2. The cyclohexylpentyl series Qa-hig n)
Experiments in which the dose-ratio was 10-20, were


















10.0 1.57 x 105 5 .796
+ 9.0 1.28 .107 5.189 5
N-Me




























Carbachol 8.0 i.4o .146
10.0 1.79 .255
6.0 2.61 x 105 5 .417
9.4 5.00 .477 (5.579)
"f" 8.8 2.78 .444 5.446 4.5 5
N-MeEt
Z 10.0 5.21 .507 (±0.021)
8.5 2.44 .587 (5.515)

















































































































































































































TABLE II CYCLOHEXYLPENTYL SERIES
Dose-ratio Mean log 1% Standard
NR from each Kr Log Kr, (±S.E.) with error as No. of
preparation
JD SD
95$ Bsdilcial per cent. Results
Limits of mean
10.7 3.23 x 105 5 .509
8.9 2.65 .420 (5.339) fi
+
8.4 2.46 •591 5.411 6 5
N-Me^ 10.4 2.55 .571 (±0.026)
10.5 2.52 .566 (5.483)
18.4 7.24 x 105 5 .860 lI
21.4 8.50 .929 1
19.7 7.77 .890 /
+ 9.7 5.44 .756 (5.761)
N Me^Et 10.9 6.16 .790 5.825 6 7
15.8 6.17 .790 (±0.026)
'
10.6 5.97 .776 (5.889)
11.5 6.45 x 105 5 .816 1
15.6 9.11 .960 I
+ 9.2 6.89 CO&• (5.789)
N MeEt2 10.2 7.69 .886 5.853(±0.025) 5.8 6 |8.4 6.12 .787 .
9.1 6.76 .830 5.917
9.8 10.97 x 105 5 1.040
6.2 6.48 .812
14.5 11.25 1.051
+ 12.4 9.49 .977 (5.835)
1
N Et
3 12.5 9.60 .982 5.922 8.5 8
8.7 6.42 .802 (±0.037)





















8.5 7.47 x 105 5 .875
8.2 7.18 .856
5.0 5.98 .600




















































11.0 8.58 .925 (5.985)
9.4 6.97 .845
10.7 8.12 .910
9.4 8.58 x 105 5 .925
9.4 8.45 .927 (5.917)




) 10.2 9.16 .962 (±0.042)/ 15.7 L4.7 1.167 (6.155)
14.5 L5.27 1.120
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used to calculate the affinity constants. The mean log
affinity constant lies between 5.0 and 6.0 and the
standard errors lie within 6-12 per cent. Though the
affinity for the members of the series is a little higher
for the
thar/phenylpentyl series,the change of affinity with
is the
structure,^/similar in/two series up to the methylpyrro-
lidinium compound, after this the affinity of the cyclo-
hexyl compounds continued to increase, unlike the phenyl-
pentyl series in which it declined (Pig. IV,. page 48).
5. The phenylacetoxy ethyl series (Table III)
Experiments in which the dose-ratio was 4-20, were
used to calculate the affinity constant. The values
the
obtained for the affinity constants were/lowest amongst
the acetylcholine analogues tested and the means of the
log affinity lie between 4.5 - 5.8. The standard errors
were found to lie between 1.8 - 9.0 per cent. As with
the phenylpentyl series the affinity sharply rises with
the successive ethylation up to triethyl compound. With
pyrrolidinium and piperidinium compounds the ethylated
members had significantly higher affinity than their
methylated homologues.
4. The cyclohexylacetoxyethyl series (TablelV)
Only the first four members of this series were
tested. Experiments in which the dose-ratio was 7-26
were used to calculate the affinity constants. The

















4.0 3.73 x 104 4.572
9.0 3.29 .517
10.0 3.80 .580 (4.504)















16.9 1.32 x 105 5 .121
20.7 1.64 .215
13.5 1.04 .017 (5.038)
+
15.9 1.24 .093 5.099
N Me-Et
%








6.7 1.43 x 105 5 .155
10.3 2.35 .371
10.0 2.27 .356 (5.273)
10.2 2.31 .364 5.351















13.3 6.14 x 105 COCO•m
13.7 6.32 .801
14.1 6.55 .816 (5.765)
13.4 6.21 .793 5.785 1.8 7































14.0 16.8 1.225 (4.989)














9.2 4.09 x 105 5 .612
9.5 4.15 .616
7.1 5.05 .484
8.4 5.70 .568 (5.555)
N Et
\ 8.5 5.75


















5.0 2.08 x 105 5 .518
8.5 1.82 .260
5.7 1.17 .068 (5.116)/ ~\+ \N Me / 9.7 1.44 .158 5.194 7.4 7
\ J 10.5 1.56 .195 (±0.052)
9.0 1.55 .124 (5.272)
11.4 1.74 .240
7.9 5.46 x 105 5 .559
8.0 5.55 .548
8.2 5.59 .555 (5.489)






























8.8 9.69 x 10* 4 .986
9.8 10.93 1.039
10.0 11.30 1.053
8.5 9.30 .969 (4.927)
•
+


































13.8 3.26 .513 (±0.022) 5 9
16.3 3.82 .582 (5.537)
15.9 3.73 .572
101.0 2.50 .398
13.7 3.18 X 105 5 .502
13.7 3.16 .500
13.1 3.03 .481 (5.473)





















































means of the log affinity lie between 5.0 and 5.6. The
standard errors were found to lie between 4-8 per cent.
■
The effects of changes in structure on the affinity of
\
these compounds are very similar to the effects on
#
affinity of those of the cyclohexylpentyl series, even
though the esters have lower affinity.
5. The diphenylpentyl series ( Table V)
The affinity constants were calculated from experi¬
ments in which the dose-ratio was 10-85. The means of
the log affinity lie between 6.6 - 7.3 and the standard
errors of the estimates for each member of the series
lie between 3-9 per cent. The most striking feature of
this series is that the affinity rises significantly up
to the methyldiethyl compound but with further ethylation
as with triethyl^the affinity falls significantly, even
below that of the trimethyl compound. Moreover,
contrary to the phenylpentyl series, the affinity goes
up with the methylpyrrolidinium compound and with the
remaining members of the series it gradually declines
till it reaches the lowest value for the series with the
ethylpiperidinium compound (Pig. IV, page 48).
6. The diphenylethoxyethyl series ( Table VI)
The affinity constants were calculated from the
experiments in which the dose-ratio was about 10. The
mean values of the log affinity lie between 6.0 and 6.6.




4ean log K33 Standard
NR
from each Kg Log 10 (± S.E.) with error as No. of
preparation
JD JD
95% Fiducial per cent. Results
Limits of mean
45.5 8.89 x 106 6 .949
56.8 9.10 .959
48.5 9.85 .995 (6.852)
+
N Me 10.0 7.60 .881 6.950 7
5 54.5 8.90 .949 (to.o4o) 9.2
11.9 9.05 .957 (7.048)
55.0 9.20 .964
85.7 2.15 x 107 7 .552
85.5 2.15 OJ• (7.174)
+ 65.5 1.64 .215 7.257 6.9 5
N Me^Et 61.0 1.50 .176 (±0.050)
17.9 1.69 .228 (7.540)
20.4 9.88 x 106 6 .995
+
58.0 14.40 1.158 (7.019)
N MeEt2 54.9 15.70 1.155 7.108 7.4 5
15.6 12.55 1.100 (±0.052)
12.2 14.10 1.149 (7.197)
19.8 4.77 x 10 6 .679
20.5 4.91 .691 (6.675)
+ 20.0 4.99 COasS£>• 6.712 5.2 5
N Et,5 12.5 5.60 .748 (±0.014)
















25.3 7.84 x lo6 6 .894 (6.787)
/
4* 31.0 9.50 .978 6.898 8.0 4
N Me 33.4 8.10 .909 (±0.035)
\ 20.4 6.46 .810 (7.009)





















59.7 4.15 x 106 6 .618
35.6 5.76 .753 (6.606)
/ A
+ \ 27.0 4.37 .641 6.670 5.3 5
N Me
\
15.0 4.66 .668 (±0.023)
1
15.0 4.66 .668 (6.734)
10.9 3.30 x 10 6 .519
13.7 4.20 .623
10.2 3.07 .487 (6.536)
14.9 4.65 .668























10.2 2.30 x 106 6 .362
10.5 2.38 .377
























11.2 5.10 X 106 6 .708
9.4 4.18 .621






















9.4 4.21 x 106 6 .624
8.1 3.54 .549
7.8 3.38 .529 (6.497)
+
















7.9 2.30 X 106 6 .362
6.8 1.95 .290
8.7 2.56 .408 (6.315)


































11.0 2.56 .408 (6.437)













8.0 3.58 x 10 6 .554
23.0 5.53 .743
+/
8.0 3.58 .554 (6.523)
8.2 3.61 .556 6.589
N Et
\











10.7 1.62 x 106 6 .210
9.6 1.49 .175
9.3 1.38 .140 (6.131)
+/ \ 8.2 1.21 .083 6.182 4.8 7
N Me / 10.8 1.63 .212 (±0.021)
\ J 10.5 1.59 .201 (6.233)
11.8 1.80 . .255
6.0 1.30 x 106 6 .114
6.2 1.32 .121
10.0 1.50 .176 (6.130)
/ \ 9.8 1.46 .164 6.151 2 8N Et )
9.2 1.36 .134 (±0.009)
\ J 10.3 1.54 .188 (6.172)
9.7 1.46 .164
9.5 1.41 .149




















































































N.B. Comparison between the mean log affinity, con'st.antobtained by Scott and
myself shows that -
* '
(1) mean values for R N Me^ and R N Me2Et are not significantly different
at«.Probability level of 0.05.
4* +
(2) Scott obtained the mean values of R N MeEtg and r'n Et^ which are
significantly higher than those obtained by me, at a Probability
level of 0.001.
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The standard errors were only within 2-7 per cent. The
effects of changes in structure on the affinity of these
compounds are very similar to the effects of changes of
those of the diphenylpentyl series, even though the
ethers have a 'lower:- affinity.
The first four members of this series were also
tested, in a slightly different method by Scott (1962),
and the dose-ratios were calculated graphically. The
values for the affinity constants were shown in Table
YIA for comparison.
The results obtained by me for trimethyl and ethyl-
dimethyl ammonium compounds do not significantly differ
from those obtained by Scott at a probability level of
0.05. However, the results obtained by me for the
methyldiethyl and triethyl ammonium compounds are signi¬
ficantly lower than those obtained by him, even at a
probability level of 0.001.
7. The phenylcyclohexyl acetoxyethyl series (Table VII)
The affinity constants were calculated from experi¬
ments in which the dose-ratios lie between 10-40. The
affinity of these compounds have the highest values
amongst the acetylcholine analogues tested. The mean
values of the log affinity lie between 8.6 and 9.0. The
standard errors of estimates for each member of the
series lie within 2-9 per cent. The most important
featurej of this series ;is that with the introduction
TABLE VII IBENYLOTCMHEXYLACETOXYETHYL SERIES
4-
Dose-ratio Vfean log % StandardT
MR from each Kr Log K_ (±S.E.) with error as No. of
preparation
JD £5








15.0 3.53 .548 (8.445)
N Me,3 15.0 3.57 .553 8.504 5.5 7
15.0 2.94 .468 (±0.024)
16.0 3.98 .600 (8.563)
58.2
B
9.30 X 10 a•00
56.1 8.78 .944
58.3 9.33 .970
+ 39.6 9,89 .995 (8.867)
N Me^Et 3^.7 8.43 .926 8.890 2.3 9
26.5 6.37 -=*■0CO• (±0.010)
23.7 5.68 .754 (8.913)
33.7 8.18 .913
24.3 5.82 .765
18.5 4.37 x 10b 8 .641
31.2 7.55 COr-00•
21.4 5.09 .707 (8.676)
+ 24.7 5.93 .773 8.771 9.0 7
N MeEtg 29.7 7.18 .856 (±0.039)
31.6 7.64 00CO• (8.866)
19.0 4.54 .657 >
15.3 3.58 x 10a 8 .554
16.7 3.92 .593
15.4 3.59 .555 (8.521) 4.4 8
19.4 4.60 .663 8.566
|
N Et 14.5 3.38 .529 (±0.019)
5









































































































































Summary of results for acetylcholine analogues.
Mean log.values for affinity with 95$ Fiducial limits in parentheses.






















































































































(5.709) (5.860) (5.601) (6.914) (6.655) (8.701)



































of both the benzene and cyclohexane rings together in
the acetyl moiety the affinity has increased by about
10,000 fold when compared with the affinity of the com¬
pounds containing a single benzene or cyclohexane ring.
Although the affinity for the series is higher than the
diphenylpentyl and diphenylethoxyethyl series, the
effect of changes in structure on affinity are similar
to the effect on affinity of those of the diphenylpentyl
and diphenylethoxyethyl series.
The affinity constants for the atropine analogues
The affinity constants of the three series of
tropine derivatives, for the guinea-pig ileum, are shown
in Tables VIII - XIII and summarised in Table XIV.
1. The benzilovltronine alkvl iodides (Tables VIII and IX)
The affinity of the members of this series are the
highest of all the compound tested. The mean values
of log affinity constants lie between 8.0 and 10.5. The
affinity constants were calculated from experiments in
which, usually, the dose-ratios were comparatively higher
than in the other series. This did not affect the
*
result, as can be seen from the graph shown in Fig. II
(page 26). The standard errors were within k-8 per cent.
The results show that the values for the ethylated
homologues were significantly lower than the methylated

























1175.0 3.49 •543 (10.363)
233.0 1.97 .295 10.443 8.3 11
350.0 2.08 •318 (-O.Q56)




38.0 1.64 x 109 9 .215
26.5 1.09 .037
29.6 1.22 .086
Et 33.0 1.38 .140 (9.061)
29.O 1.22 .086 9.100 3-9 9
30.0 1.24 .093 (±0.017)






















816.0 7.02 x 109 9 .846
— 1 ■
465.0 5.49 .740
468.0 5-50 .740 (9.765)








19.0 17.10 x 107 7 1.233
10.4 9.17 .962
Et 12.3 9.94 •997 (7-993)
14.0 11.66 I.067 8.088 9 7
19.8 16.15 1.206 (-0.039)




ones, in both the tropine and pseudotropine derivatives
at a probability level of 0.001. The affinity of the
pseudotropine derivativeswas" significantly lower than
those of the tropine derivatives at a probability level
of 0.001.
2. The diphenyl acetyl tropine alkyl iodides (TablesX&XI)
Experiments from which the affinity constants were
calculated for the methylated homologues had a higher
dose-ratio than for the ethylated ones, in both tropine
and pseudotropine derivatives. The mean values of log
affinity constants lie between 6.9 and 8.7. The
standard errors fall between 4-12 per cent. The effect
of changes in structure on affinity are similar to those
in the benziloyl tropine series.
3. Tropine alkyl iodides (Tables XII and XIII)
l
Experiments from which the affinities were calcula¬
ted had a very low dose-ratio. These compounds have
the lowest affinity amongst the compounds tested. The
mean values of log affinity constants lie at about 3.0.
The results show no significant difference amongst the
members of the series at a probability level of 0.05.
The test for competitive antagonism ( Table XV)
A few of the compounds of the acetylcholine
analogues were selected at random to see if they were
















466.0 4.67 x 108 8 .669
147.0 4.41 .644 (8.618)
Me - 5.29 .723 8.669
129.0 5.85 .586 (±0.02) 4.6 6

























































































3-75 1.37 x 10? 3 .137
2.^0 1.65 .218 (3.085)
Me 2.50 1.81 .258 3.I66
(-0.039)
2.23 1.53 .185 9.0 5






































2.8 1.11 x 105 3 .045
3-3 1.41 .149 (3.065)
Me 3-5 1.56 .193 3.142 6.9 6
(-0.030)
3.7 1.70 0OJ•























TABLE XIV SUMMARY CF RESULTS FOR THE ATROPINE ANALOGUES
MEAN LOG AFFINITY CONSTANTS WITH 95# CONFIDENCE LIMITS
"Body"
TROPINE PSEUDO TROPINE






































Summary of results; for test for antagonism.

















107.0 10.41 1.44 1.09
^CB2)5S-Me2Et 87.0 16.43 1.37 1.15
~^)(CH2)5l Etj 132.0 13.14 1.34 1.17
N(CH2)5He 112.0 10.74 1.50 1.09
Ph(CE2)5N-Et 103.0 I8.4 1.12 1.17
Ph2CH(CH2)4M-Me5 102.0 10.67 1.18 1.09
4"
Ph2CH(CH2)4H-MeEt2 116.0 12.55 1.26 1.11
Ph2CH(CH2)4H-Et5 91.0 12.22 1.29 1.11
Ph2CH(CH2)4M-Me 113.0 12.50 1.08 1.11
ft 99.0 10.0 1.15 1.09
Ph2CH(CH2)4M-Me 82.0 15.0 1.16 1.13
Papaverine 96.4 4.06 3.84 1.03
MB. The mean dose-ratio for atropine of 104.0 was used to calculate the
value for column 5.
40
the
competitive antagonists and were tested by/atropine
method. The results are summarised in Table XV arid 1 j
show a fair agreement between the observed and theoreti¬
cal values for the compounds.
The observed mean values for 11 compounds was 1.26
and the theoretical mean value was 1.11. These means,
however, differ from each other at probability of 0.005.
Papaverine (4.0 x 10~^ M) produced a dose-ratio of
ileum
4.06 alone on guinea-pig /rind it produced a dose-ratio of
—7
3.84 when combined with atropine (10 1 M), whereas, the
I
theoretical value for competition is only 1.03.
—7
The mean dose-ratio for atropine (10 M) was 104.0
and this value was used to calculate the theoretical
values. The mean value of affinity of atropine for the
guinea-pig ileum was 10^*^^ (1.023 x 10^) litre/mole.
The effect of temperature on affinity
.
Table XVI summarises the effects of temperature
on the affinity constants. The mean value of log
affinity constant at 27°C and 37°C were found to be
5.396 and 5.213 respectively. The results indicate
that with the rise of temperature the affinity decreases
significantly. The mean values are significantly
different at a probability level of 0.001.
Prom these two values of affinity the difference in
enthalpy, 4H, and the entropy, ^S, can be calculated
after Dixon and Webb (1964).
TABLE OO/T
Effect of temperature on the affinity constant of Phenylacetoxyethylmethyl




estimates of Kb log Kb
individual
estimates of K4, log Kb
1 2.96x10 5 5.471 1.93x105 5„286
2 3.65 .502 1.54 .188
3 2.79 .446 1.26 ol00
4 2.86 .456 1.50 .176
5 2.30 .362 1.71 .233




8 2.53 .403 1.79 .253
9 2.39 .378 1.91 .281
10 1.72 .236 1.39 .248
11 2.42 .388 1.77 .248
12 1.94 .288 1.43 .155













The means are significantly different at a probability level of 0.05 (P<0 .001).
Temperature Co-efficient (Q1Q) = 5.396 - 5.213 = 0.183 and taking antilog, it
becomes 1.524.
- - 2.303 R T log Kg cal/mole.
T~ 'r:
4FT300 = - 7404.00 cal/mole.
4^310 = - 7391.33 cal/mole.
V_L.
o d log K-q
(2) 4H = 2.303 R T
d ^ cal/mole.
4H = - 8884.28 cal/mole.
(3) 4S = ^ H - <4 F cai/aeg.
4S = - 4.816 cal/deg.
-caton and Rang (1966) reported similar results.
The estimation of affinity constants, using different
agonists
The affinity constants of some of the antagonists
were measured using different agonists. The results
are shown in TablesXFJI—XIX.. 1. The affinity constants
of some of the members of the phenylpentyl series were
determined using acetylcholine and carbachol as agonists.
s
At a probability level of 0.05 there was no significant
i
difference between the mean values obtained with
different agonists. The affinity of phenylpentylethyl-
pyrrolidinium was determined using carbachol and pentyl-
|
trimethyl ammonium on the same piece of guinea-pig ileum,
in one group of experiments, and carbachol and ethoxy-
ethyltrimethyl ammonium, in the same piece of ileum, in
another group of experiments. The results are shown in
™ jvtta
Log affinity constants of Phenylpentyl trimethyl ammonium on guinea pig



























Log affinity constant of Phenylpentyl diethyl methyl ammonium on guinea
pig ileum with acetylcholine and carbachol as agonists. The values obtained




















Log affinity constant of Phenylpentyl trielhyl ammonium on guinea pig
ileum, with acetylcholine and carbachol as agonists. The values obtained
































Log affinity constants of Phenyl-pentylethyl pyrrolidinium, on guinea pig
ileum with carbachol and pentyltrimethyl ammonium as agonists. The values
obtained from the same piece of tissue.































Log affinity constant of phenyl pentylethyl pyrrolidinium on guniea pig
ileum with carbachol and ethoxyethyl-terimethyl ammonium as agonists. The
value obtained from the same piece of tissue.




























Tables XVIII-XIX. There was, again, no significant
difference between the means at a probability level of
0.05.
The estimation of affinity constants for various tissues
To see if there is any variability in affinity
constants for different tissues, some of the compounds
were tested, d..n the various tissue-preparations. The
values are shown in Tables XX-XXIII.
Table XX shows the results obtained for diphenyl-
acetyltropine ethiodide on guinea-pig ileum, longitudinal
strip muscle and taenia coli muscle. There was no sig¬
nificant difference between the three means, at a
probability level of O.O5. the
However, the means obtained for/^phenylcyclohexyl-
acetoxyethyl-trimethylammonium compound on the guinea-pig:
ileum and taenia coli muscle were found to be signifi¬
cantly different at a probability level of 0.00-1
(Table XXI).
All the eight members of the phenylacetoxyethyl
series were tested on rat colon preparations and on
guinea—pig ileum. The mean values are shown in Table XXII
With the exception of three members, the results
show no significant difference at a probability level of
O.O5. The affinity constant of the trimethyl compound,
on the rat colon, was significantly higher than that
on the other tissue at,a probability level of ©.005»The
TABLE XX.



















































































The means are different
at probability of 0.05.
(F^J.OOl)
TABLE XX,II




























































































5.03 0.02>P>.01 12 significant(P<0.05)
Figures in the parentheses indicate the number of individual estimations on which
the mean is based.
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affinity constants of the ethylpyrrolidinium and ethyl-
pip eridinium compounds on the rat colon were signifi¬
cantly lower, at a probability level of 0.005 and 0.02
respectively, than those on the guinea-pig ileum.
Phenylacetoxyethyl-methylpiperidinium and diphenyl-
ethoxyethyltriaethyl ammonium compounds were tested on
rabbit auricle preparations and guinea-pig ileum. The
results are shown in Table XX'lil. These mean values
show no significant difference at a probability level of
0.05.
TABLE XXII1








































1.49 0.2)2)0.1 8 notsignific
Figures in the parentheses indicate the number of individual estimates on which
the mean is based.
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DISCUS S I 0 N
4-5
Variance of the results
When assessing the scatter of the estimates of
affinity constant (Kg), Barlow, Scott and Stephenson
(1963) and Abramson (1964) have assumed that there is a
normal distribution of estimates of log K,,. This
follows from the suggestion by Gaddum (1945,1953) that
it is log dose rather than dose which is distributed
normally. Barlow, Scott and Stephenson (1963) assumed
that their values of the standard error of log K.,-, were
estimates of the variance of log Kg in general about a
true value, and therefore used a pooled estimate of the
variance of their results with all the compounds, when
calculating the fiducial limits of log Kg or of ratios
of log Kg.
During the testing of the compounds described above,
however, it seemed possible that the variance with some
types of compounds might be greater than with others.
The fiducial limits of log Kg for the individual com¬
pounds (shown in Tables I-XIV) have, therefore, been
calculated using the observed variance with the parti¬
cular compound alone. If there really is a difference
in the variance of different types of compounds, it would
seem likely that this is related to the chemical nature
of the compound and accordingly the variance amongst the
series has been calculated and shown in TableXXIV.
There are differences amongst the series and there are
also differences within a series but it is very difficult
TABLE XXIV















to come to any conclusion as to which groups are
associated with high variance. The biggest values of
the standard error are 11-12 per cent, and most values
are less than 10 per cent, and this is very similar to
the values obtained by Schild (1947), Barlow, Scott and
Stephenson (1963) and by Arunlakshana and Schild (1959).
In working out the fiducial limits of the log of ratios
of the affinity constants (log K /K) a pooled estimatecl
of the variance has been taken, based on all the esti¬
mates of log Kg, in the same way as was done by Barlow,
Scott and Stephenson (1963). Prom what has been found
in Table XXIV this may lead to an over optimistic value
of the fiducial limits in some instances but the limits
should not be grossly distorted; for example, the fidu-
K'a
cial limits (P = 0.05) of the log for cyclohexyl-
pentylethyldimethyl ammonium and trimethyl ammonium are
5.825 - 5.411 = 0.414 ± 0.102
with the variance for the series (which is the biggest
of all the variances) and
0.414 ± 0.078
with the pooled variance.
Different agonists: . ^ . .
The experiments with different agonists (page 41 )
confirm that the antagonists are blocking the same
rgceptors, and justifies the use of carbachol rather than
acetylcholine in the majority of the experiments. The
use of carbachol prevents any complications which might
arise because the compounds blocked cholinessterases;
4-7
there is a real possibility that this may happen,
because compounds which resemble acetylcholine enough to
block acetylcholine receptors in the ileum may block the
destruction of acetylcholine by cholincesterases.
Different tissues:
It is also striking that in general the affinities
for the receptors in the guinea-pig ileum, longitudinal
strip muscle, taenia coli, rat colon and rabbit auricle
are very similar. There are some differences which are
significant but none of these is big. The results are
similar to those obtained by Arunlakshana and Schild
(1959) and Hawkins and Schild (1951) with antihistamine
drugs, who found that the affinity of these was the same
for histamine receptors in a variety of different
tissues.
Different temperatures:
The experiments on affinity at different tempera¬
tures indicate a temperature coefficient of 1.5 for the
affinity constant of phenylacetoxyethyl-Nmethylpiperidi-
nium. This is similar to the coefficient for the
binding of many substrates and enzymes (Dixon and Webb,
1964). It indicates that the process of association is
exothermic and the process of dissociation is endo-
thermic. It would be desirable to have information
about more compounds but unfortunately the measurement of
the temperature coefficient for single compound is very
laborious and it has not been possible to study them
systematically.
Test for competition . .
The results of the tests for competition justify the
48
assumption that the compounds are acting competitively
in the concentrations at which Kg is estimated. When
there was any doubt about the nature of the antagonism,
I
because the graph of (dose-ratio - 1) against antagonist
concentration was not linear, the compound was subjected
to the atropine test (page 26). All the compounds so
tested (Table XV ) appeared to be competitive
antagonists in the lower concentrations and the
estimates of Kg were therefore made in this range. The
reliability of the atropine test is shown by the results
with papaverine.
The effect of changes in the composition in the
' '
'(Tables XXV-XXVII)
onium group is illustrated in Figures IV andV/. In the
first of these log K is plotted against the composition





+ + + + y
Me^N, Me2EtN, MeEtgN, Et^K, MeN
-/ \
EtK )• In the second, an attempt has been made to
\ /
arrange these groups in order of size, by adding together
the atomic weights of the atoms forming the onium groups
(omitting the "body" of the molecule). In addition to
the compounds tested in this work, results are also
included for the benzilic and diphenylacetyl esters
studied by Abramson and by Scott and also for n-pentyl
compounds studied by Stephenson (unpublished). The
first four compounds of the diphenylethoxyethyl series
Me3N MeftN MeEtgN E^N McnQ Et*lQ Me O Et<0
FIGURE1V. Graph of log affinity (ordinate) and
composition of the onium group (abscissa).
FIGURE1VA. Graph of log affinity and composition of
the onium group. Vertical lines indicate 95 per cent,
confidence limits calculated for each compound.
I ON I C WEIGHT
FIGURE V.. Graph showing the relationship "between log
affinity and ionic weight of the groups attached to the
quaternary nitrogen atom. "Lower analogues" show a
progressive rise in affinity with increasing ionic weight
whereas the "higher analogues" show a progressive
decline of affinity.
Effect of constitution of onium group on affinity constant of the compounds
R HRj .
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TABLSXXV D CYCIOHEXYLACETOXY-ETHYTi SERTrnFi
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TABLEXXV E PHEFYLCYC LOHEXYLACETOXYETHYL SERIES
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Dvrroliflin-n™ rePlacinS N-methyl-pyrrolidiniuo (k) by N-ethyl-lldl ium (Kx) and R-methyl piperidinium (K) by N-ethyl piperidinium
. a Jn parentheses indicate 95$ confidence limits, with avariance of 0.00486.
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Summary of results: values of -f
onium group for the acetylcholine
confidence limits.
at 57°C accompanying changes in the






























































































































































were also studied by Scott and the results of the first
two compounds are not significantly different from those
obtained in this work. The values for the methyldi-
ethyl and triethyl ammonium compounds were, however,
significantly different from Scott's results (P^0.001;
Table VIA) but the differences are not big.
In all the series of acetylcholine analogues
tested the replacement of one methyl group by an ethyl
group increased the affinity 2-4 fold. This is in full
agreement math the results of Ing, Dawes and Wajda
(1945), Scott (1962) and Abramson (1964). The effect
on affinity of further replacement of methyl groups by
ethyl, however, is different in the different series of
compounds. This indicates that the effect of changes
in the composition of the onium groups is not really
independent of the nature of the "body" of the molecule
and raises two questions;
(1) Is the effect on affinity of making changes in
the onium group related to the affinity of the compounds
themselves, being greater in the molecules with lower
affinity than those with the high affinity? This might
be expected from Burgen's suggestions.
(2) Is the variation in the effect on affinity of
replacing methyl by ethyl so great as to make it
impossible to predict likely changes in the affinity of
agonists?
Examination of FiguresIV andlVA does not suggest
50
that changes in the composition of the onium groups
affect molecules with lower affinity (lower analogues)
more than with higher affinity (higher analogues). In
TableXXVIIIthe affinity is compared with the biggest
differences in affinity between the members of the same
series. The biggest difference is with the phenyl-
acetoxyethyl series, which has the lowest affinity, but
with all the others the range is more or less the same
even though the affinity varies 10,000 fold. Even with
the compounds with the highest affinity the range is
wide, 0.8 to 0.9, compared with 1.2 for the phenyl-
acetoxyethyl series. The results, therefore, do not
indicate a relation between the affinity and the change
in affinity brought about by altering the onium group.
It is, however, noticeable that the position of the
compounds with highest and lowest affinity alters con¬
siderably in the series, depending on the affinity. The
triethyl and ethylpiperidinium compounds, for example,
have much higher affinity in the series with lower
affinity than in those with high affinity.
In Figure V there is a suggestion that in
the "lower analogues" an increase in size is associated
with increased affinity, whereas in the higher
analogues" an Increase in size, beyond the replacement
of one methyl group by ethyl, usually causes a decrease
in affinity. The variation in affinity with composition
of the onium groups seems to depend on whether there is
TABLE XXVIII





NMe^ Comp. Log. difference
Ph acetoxyethyl 4-53 1.252
Ph pentyl 5.18 0.715
Cyclohexyl Pentyl 5.41 0.614




acg'ipxye thyl 8.50 0.779
Benziloyloxyethyl 8.51 0.868
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one ring (phenyl or cyclohexyl) at the end of the mole¬
cule or two, i.e. there appears to be a pattern which is
common to the "lower analogues" and a rather different
pattern for the "higher analogues". It seems therefore
that the binding of the onium group will be considerably
affected by the binding of these rings which contribute
quite substantially to the affinity of the whole
molecule (see below).
The second question, the validity of using the
estimates of the affinity of the antagonists to predict
the relative affinities of agonists, must remain incom¬
pletely answered. However, in nine series of the
antagonists with different affinities, replacement of
one methyl group by an ethyl leads to an increase in
affinity of 2-4 fold and the binding of agonists must be
quite different if the same is not true with them. In
fact, Stephenson (unpublished) has found that the
affinity of pentylethyldimethyl ammonium is certainly
not less than that for pentyltrimethyl ammonium though
it may not be as much as twice. The graph for the
affinity of the pentyl compounds (FigurelV) is not
markedly different from that of the phenylacetoxyethyl
compounds.
The size of the changes in affinity with the com¬
position of the onium group indicates a change m free
energy of 0.4 - 0.8 Kcal/per methylene group and this
suggests changes in bindipgyti^ought about by Van der
W "x\(s( Vi
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Waals and/or hydrophobic forces. Because of extreme
dependence of Van der Waals forces on the close proximity
of the interacting groups, it would seem more possible
that hydrophobic forces are involved, particularly with
"lower analogues" with which affinity rises with size.
When the change in composition reduces the affinity, it
must be assumed that the parts of the molecule which
were formerly contributing to the binding can no longer
do so, or do so less efficiently. Again the magnitude
of the change in free energy is consistent with the idea
that the bonds involved are Van der Waals or hydrophobic
in nature. In some instances, e.g. v/ith the isomeric
methylpiperidinium and ethylpyrrolidinium compounds, it
is clear that the shape of the onium groups is important,
which might indicate that Van der Waals bonding is
involved rather than hydrophobic bonds. With the higher
compounds the flat pyrrolidinium compounds bind better
than the piperidinium compounds. Only with the pentyl
series the position is reversed, possibly with these the
contributions from the hydrophobic forces are more
important than those from Van der Waals forces.
[Bhe effects of changes of the constitution—of—the_
body on the adsorbabilitv are shown in TableXXlX«&. XXX.
The substitution of one phenyl or cyclohexyl ring
at the end of the molecule increased the affinity between
2.5 - 65 fold compared with that of compounds in the
mlmimrt! grouP R (body) on affinity constant of the* L3 " e affinity c°nstant of a compound is compared with
a. °. 6 m® ^"e P^enylpentyl series with the same onium group,-f indicates the difference in the free energy of adsorption; valuesin parentheses indicate 9j}0 confidence limits, with a variance of 0.00486.














































































































































































































TABLE XXIXE-. METHYL PYKROLIDBriUM COMPOUND

























































































































TABLE XXIXII ETHYL PIPERZDIHIUM COMPOUND







































Summary of the results: values of -f cal/mole at 37°G accompanying
changes in the body of the molecule of the acetylcholine analogues;
values in parentheses indicate 95^ confidence limits; compounds of
Phenylpentyl series taken as standard.
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(1455) (1875) (1263) (769) (1343) (1465) (813) (1092)
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n-pentyl series, the substitution of two phenyl rings
increased the affinity between 25 - 3162 fold and with
the substitution of one phenyl and one cyclohexyl ring
together in the compounds (with the ester link) the
affinity rose between 1995 - 79430 times that of the
corresponding n-pentyl compound. These results agree
with the observations of Meier and Hoffmann (1941),
Cunningham (1949)» Lands (1951) and Lands et al. (1956).
In terms of the free energy of adsorption, the
increase for a single phenyl ring is 1.2 - 2.0 Kcal/mole,
that for a cyclohexyl ring is 1.5 - 2.6 Kcal/mole and the
energy for two phenyl rings is 2.6 - 4.6 Kcal/mole. The
effects, however, are different in different series
(TablexxXI )• For example, in the series with a
straight methylene chain, the introduction of the second
phenyl ring has much the same effect as the introduction
of the first. When the esters are compared, however,
the introduction of the second phenyl ring has a much
bigger effect on binding (about 3 Kcal/mole as opposed
to 2 Kcal/mole). The effect is even greater when a
phenyl ring is introduced into the cyclohexyl esters,
when the binding is increased by between 4 and 5
Kcal/mole. In both the pentyl and the acetoxyethyl
series the cyclohexyl compounds have a higher affinity
than the phenyl ones. It would be interesting to have
accurate information about the dicyclohexyl compounds.
Some of these compounds have been tested by Meier and
TABLE] XXXIA
The effects of Benzene ring in the "body" on free energy of adsorption
(-f). The figures were obtained by comparison of log affinity constants
of the corresponding compounds in the various series.
























2091 2566 3520 1.2 1.7
+
NMeEt, , 4-399 i865 1975 3174 1.06 1.7
+





2077 1794 3337 0.86 1.6
tQ 4.370 1787 1730 2821 0.97 1.58
NMe
w
v • CO M VJ1 1251 1397 2935 1.13 2.38
MBt ,
\ /
> 4.576 1289 1614 2114 1.25 i.64
KB. Results for the compounds of n-pentyl series were obtained by
R.P. Stephenson. (Unpublished).
TABIE XXXIB
The effects of cyclohexyl ring in the "body" on the free energy of
absorption (~f). Figures were obtained by comparison of the log-
































Hoffmarm (1941) and levy and Tochoubar (1947) but it is
impossible to make an estimate of their affinity
constants from their (rather conflicting) observations.
The above results can equally be set out to show
that the effect of the ester group depends on the number
(Table XXXII)
of phenyl or cyclohexyl rings'. In the "lower
analogues" with only one big substituent, the ester
group invariably reduces the affinity compared with the
1
methylene analogues. In the "higher analogues",
however, the ester group appreciably increases affinity.
The ether group, on the other hand, lov^ers affinity,
even in the higher analogues.
Tropines;
~
With the tropines it is again clear that the sub¬
stitution on one end of the molecule influences the
(Table XXXIII)
binding of the other end./. The simple unesterified
derivatives of tropine all have the same rather weak
affinities. With the esters, however, the effect of
replacing a methyl group by ethyl is to reduce affinity,
in the pseudotropines more than with the tropines and in
the benzilic esters more than with diphenylacetyl esters.
Unfortunately, the monophenyl esters have not been
prepared and the only comparison which can therefore be
made is that which should show the effect of the hydroxyl
group on affinity (TableXXXIV ). The values fall within
the range 1.7 - 2.2 Kcal which is the same as the
difference between the benziloyl and diphenylacetyl
compounds studied by Scott and later by Abramson. This
table xxxii
The effect of ester and ether oxygen groups in the body on the free energy
of adsorption (-f). The figures were obtained by comparison of the log
affinity of the corresponding compounds of the series.
- Ester Group (-C0-0) Ether Group (-0-)
fe,
5
Ph ch2coo(ch2)2 Och2coo(ch2)2 PhgCH C00(CH2)2 Ph2cn ch2o(ch2)2
Ph (ch2)5 <H>(ch2)5 Ph2CH (CH2)4 Ph2CH (CH2)4
+
me,
3 -915 -632 299 -761
H-
EMe2Et -492 0COI 462 -799
+



























NB. Results for Ph2 CH GOO (CH2)2 were obtained by Abramson (1964).
TABLE XXXI11 SUMMARY OF RESULTS; RATIOS OP LOG Kg AND VALUES OF (-f)
CF THE CHANGES IN THE ALKYL-RADICAL FROM ETHIODIDE (K)
TO METHIODIDE (Ka); THE VALUES IN THE PARENTHESES
















































TABLE HXIY EFFECT ON AFFINITY AND (-f) OF REPLACIM} DIPHENYLiAGETYL
GROUP (K) m EEUZILOYL GROUP (Ka)
_
VALUES IN THE PARENTHESES INDICATE 95% CONFIDENCE LIMITS
Tropine Pseudo Tropine





























is consistent with the hydrogen bonding involving the
hydroxy1 group. The effect is the same in both
tropines and pseudotropines but is smaller with the
ethiodides than with the methiodides.,( Table XXXJV) .
Conclusions
The results obtained in the study of these
antagonists show that the assumptions of Barlow, Scott
and Stephenson (1963), that affinity is made up of com¬
ponents which are additive, is far too simple. An
extreme example is the effect of replacing esters
(—CO—0—) by ethylene (-CHgCH^-); in the monophenyl
series this increases affinity whereas in the diphenyl
series it decreases affinity. On the other hand, there
is no obvious relationship between the effects of sub-
stituents on affinity and the affinity itself. It
appears, rather, that effects of changes in structure on
affinity are related to the chemical nature of the com¬
pounds and within series, for example, within the "lower
analogues" or within the "higher analogues", the effects
do follow a regular pattern, indicating that the binding
is made up of components which are additive. The
differences between the series, however, indicate that
different types of molecule bind in different ways and
even within series it appears that there are slight
differences in the ways in which the individual compounds
become bound.
TABLE XXXV EFFECTS OH AFFINITY AMD (-f) OF THE ARRANGEMENT OF THE
3-HYDROXYL GROUP OF THE TROPIME RING;
THE RATIO IS OF,KafFOR TROPIME DERIVATIVE RELATIVE TO K,
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